Document is current

Article History

First Online: 12 January 2017

Competing interests

: HS has received study honoraria, travel expenses and consulting fees from Abbott, Acoredis, Atrium, Biosense Webster, Bioventrix, Boston Scientific, Carag, Cardiac Dimensions, CardioKinetix, Celonova, CGuard, Coherex, Comed BV, Contego, CSI, CVRx, ev3, FlowCardia, Gardia, Gore, GTIMD Medical, Guided Delivery Systems, Hemoteq, InspireMD, Kona Medical, Lumen Biomedical, Lifetech, Medtronic, Occlutech, pfm Medical, Recor, SentreHeart, Svelte Medical Systems, Terumo, Trivascular, Valtech, Vascular Dynamics, Venus Medical and Veryan; and has stock options with Cardiokinetix, Access Closure, Coherex, SMT.JS received speakers’ honoraria from Boston Scientific Corporation.UCH has received grant support and honoraria from Boston Scientific Corporation/Vessix Vascular, grant support and consultancy fees from Medtronic, Inc., and consultancy fees from St Jude Medical.IM received honoraria and consulting fees from Boston Scientific.MA has received honoraria for advisory board meetings from Vessix, Boston Scientific Corporation, and Cordis and speakers’ honoraria from Cordis and CVRx.JD-C is an employee of Boston Scientific Corporation and holds stock in the company. The remaining authors declare no conflict of interest.